Skip to main content

GSK, other drugmakers bet on post-Brexit UK science

By December 11, 2017News
GlaxoSmithKline-gsk-logo

GlaxoSmithKline-gsk-logo

The move is welcome news for Prime Minister Theresa May, who has struggled to win over large sections of industry as Britain prepares to leave the European Union.

{iframe}https://uk.reuters.com/article/us-britain-eu-pharmaceuticals/gsk-other-drugmakers-bet-on-post-brexit-uk-science-idUKKBN1E001G{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.